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ABSTRACT
In March of 2020, the World Health Organization declared a global pandemic due
to the ongoing spread of SARS-CoV-2, the causative agent of COVID-19 disease. While
scientific developers were seeking to understand the biochemical mechanism of SARSCoV-2, political and public health leaders implemented non-pharmaceutical
interventions, such as social distancing measures, to reduce the transmission of COVID19. As the world began to adjust to the new realities, the race to create an effective
vaccine was on. With the later development of the COVID-19 vaccine, receptiveness to
the vaccine across the world varied, and in the United States, vaccine hesitancy was an
apparent phenomenon, especially in Mississippi. This study sought to explore the
relationship between the perceptions of COVID-19 vaccine safety and vaccine uptake
intention among African American adults in Mississippi. Participants were recruited via
social media, email, social networks, and community-based organizations to participate
in an online survey. Eligible participants for this study were African American,
Mississippi residents over the age of 18 years old. Pearson correlation analyses revealed
age, education level, income levels, and knowing a family member who experienced an
adverse reaction were associated with vaccine hesitancy. Linear regression results
showed perceptions of vaccine safety for self/community, not vaccine safety perceptions,
were a significant predictor of vaccine hesitancy, after controlling for several variables.
Limitations of this study include limited generalizability. Future studies on vaccine
hesitancy in African Americans should examine vaccine hesitancy while accounting for
any historical or current events such as the Tuskegee experiment that may have led to
medical mistrust.
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Introduction
SARS Coronavirus 19: A Global Pandemic
In January 2020, the members of the World Health Organization (WHO) noticed
rising pneumonia cases in China with no known cause (Pneumonia of Unknown Cause -China). As members continued to monitor the cases of pneumonia, it was reported that a
novel coronavirus was the causative agent of the pneumonia cases (Khan). Coronavirus
(CoV) is a large viral family that causes upper respiratory infections. Within this family,
there are several types of coronaviruses. Common reservoirs for these coronaviruses are
in animals including bats, pigs, and cats, but coronaviruses are not limited to animals. In
the 1960s, scientists began to discover human coronaviruses. Of the seven coronaviruses
affecting humans, Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) was
discovered between 2002 and 2003 (CDC SARS Response Timeline).
With this knowledge in mind, Chinese scientists hypothesized coronavirus was a
pneumonia-causing agent in patients. “Chinese authorities subsequently reported that
laboratory tests ruled out SARS-CoV, MERS-CoV, influenza, avian influenza,
adenovirus and other common respiratory pathogens” (WHO Statement regarding cluster
of pneumonia cases in Wuhan, China) As scientists and physicians continued to rule out
known coronaviruses, it was determined a novel or new coronavirus caused the
pneumonia cases in Wuhan, China.
As scientists began to identify and track these cases, the World Health
Organization declared a public health emergency of international concern (PHEIC).
According to the WHO, a PHEIC is defined as “an extraordinary event which is
determined to constitute a public health risk to other states through the international
1

spread of disease and to potentially require a coordinated international response”
(International Health Regulations). As countries around the world began to prepare for
the effects of COVID-19 outbreaks, cases continued to rise. On March 11, 2020, the
WHO Director General stated they “made the assessment that COVID-19 can be
characterized as a pandemic” (WHO Director-General's Opening Remarks at the Media
Briefing on COVID-19 - 11 March 2020). The Director-General deemed it imperative
countries took proactive measures in protecting their citizens. In a press conference, the
Director General believed the course of this pandemic could change if countries “detect,
test, treat, isolate, trace, and mobilize their people in the response” (WHO Dir. Gen’s
opening remarks briefing on COVID-19).
Efforts to Control and Contain the Spread of COVID-19 in the United States
In the United States, following the declaration from the WHO Director General,
President Donald J. Trump “proclaim[ed] that the COVID-19 outbreak in the United
States constitutes a national emergency…” (Proclaim on Decl. a Nat’l Emergency. 1). As
the citizens of the United States began to understand the severity of this new disease,
states, local towns, businesses, and schools began to develop a plan in response to the
pending pandemic. In congruence to the national emergency declared by President
Trump, California Governor, Gavin Newsom, issued the first stay-at-home orders on
March 19, 2020, making California the first state to do so. Under these orders, “all
individuals living in the state of California are to stay home or at their place of residence
except as needed to maintain continuity of operations of the federal critical
infrastructure” (Executive Order N-33-20 1). During this time, it was expected citizens
only leave their homes for essential items such as food and medicine. Healthcare workers
2

were expected to go to work while other occupations were forced to adapt to hybrid or
online working environments.
As the months continued, other states in the United States began to follow
California’s lead issuing stay-at-home orders, including Mississippi. In Mississippi,
Governor Tate Reeves signed Executive Order 1466 which implemented a “shelter in
place order” on March 31st that went to effect on April 3rd (Executive Order NO. 1466 1).
The stipulations of the shelter in place order had specific conditions: individuals will only
be allowed to leave their house for health-related reasons, to obtain food and common
household supplies, to engage in individual outdoor activity, and to work in an essential
business. Those businesses include but are not limited to, hospitals, healthcare facilities,
grocery stores, pharmacies, childcare centers, as well as a variety of functions from
sectors such as utilities, transportation, agriculture, manufacturing, and finance and
banking. This order was implemented in hopes of curving the number of COVID-19
cases and deaths in Mississippi. In addition to the statewide shelter in place order, the
governor also issued a statewide mask mandate. In an executive order, the Governor
instructed every Mississippian to wear a form of face-covering while inside public spaces
or spaces where the minimum six-foot distance requirement could not be met. Since
COVID-19 is a respiratory virus and causes a respiratory infection, it was important to
limit transmission by covering the nose and the mouth. With these measures in place,
Mississippi began to see low occurrences of COVID cases, but this began to change
nearing June as President Trump and Governor Reeves began to allow businesses to
reopen. The average number of new cases in Mississippi peaked to over 1,000 cases in
July of 2020. Seeing this, the Governor decided to issue an order allowing specific school
3

districts to delay their start time for the next academic year as they attempted to control
the number of cases.
According to the Mississippi Department of Health (MSDH), the number of
COVID-19 cases went from less than 1,000 cases in April of 2020 to more than 5,000
cases in October of 2021 (MSDH COVID-19 Vaccination Reporting). Of these confirmed
cases, 35.5% of them have been confirmed in Black people and 38.8% of them are
confirmed deaths of Black people. As of October 7, 2021, there were 3,714 deaths
between March 1, 2020, and September 30, 2021. On March 27, 2020, the Secretary of
Health and Human Services, Alex M. Azar II, “declared that circumstances exist
justifying the authorization of emergency use of drugs and biological products during the
COVID-19 pandemic…” (Regulations.gov). Declaring the Emergency Use Authorization
(EUA) authorizes the use of medical countermeasures when a national public health
threat arises. Medical countermeasures include “biologic products, drugs, and devices”
(FDA.gov). In the case of COVID-19, the vaccines would be considered a
biological product. This pronouncement set off a cascade of research to develop vaccines
to fight the pandemic. In December 2020, the U.S. Food and Drug Administration issued
authorization for two COVID-19 vaccines to be used to counter the number of cases.
With two vaccines available, vaccines began to be distributed among the eligible, and as
eligibility expanded, more Americans were becoming vaccinated. While American
citizens slowly began to become receptive of the medical counter measure that many had
hoped would flatten the curve, some citizens were hesitant to receive the COVID-19
vaccine. In Mississippi, according to the MSDH COVID-19 Vaccination Reporting
report, Mississippi experienced an initial influx of Mississippians being vaccinated
4

followed by a steady decline between December 2020 and July 2021 (MSDH COVID-19
Vaccination Reporting). Additionally, according to the John Hopkins University
Coronavirus Resource Center, only 50.93% of Mississippi’s population is vaccinated.
The question has evolved to, “why aren’t the other 49% of Mississippians getting
vaccinated if they are eligible?”
Vaccine Hesitancy in African Americans
According to the SAGE Working Group, Vaccine Hesitancy “refers to delay in
acceptance or refusal of vaccination despite availability of vaccination services… The
Vaccine Hesitancy Determinants Matrix displays the factors influencing the behavioral
decision to accept, delay or reject some or all vaccines under three categories: contextual,
individual and group, and vaccine/vaccination-specific influences” (MacDonald et al. 1).
This model indicates vaccine hesitancy is a multifaceted phenomenon and in the black
community, one important factor influencing vaccine hesitancy is scientific or medical
mistrust that is rooted in racism, prejudice, and historical experimental research (Schaff et
al. 1).
History portrays unethical treatment of African Americans in medical research
and advancement. Two prominent cases of unethical treatment include the story of
Henrietta Lacks, gynecological research on enslaved black women, and the Tuskegee
experiment. In “More than Tuskegee: Understanding Mistrust about Research
Participation,” researchers found mistrust in the healthcare system as a pivotal influence
discouraging participant engagement in medical research (Schaff et al. 4-6). Historical
events such as the Tuskegee experiment and ongoing discrimination were credited to
perpetuating reasons (Schaff, Darrell P., et al. 1). While many African Americans have
5

taken the vaccine, these lingering feelings of medical mistrust in the healthcare system
embedded in the community may be one reason there are many African Americans still
hesitant to obtain the COVID-19 vaccine.
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REVIEW OF THE EVIDENCE OF VACCINE
HESITANCY AMONG AFRICAN AMERICANS
While the ongoing pandemic has yielded numerous studies into COVID-19 over
the last two years, vaccine hesitancy is not a new concept. Prior studies have explored
vaccine uptake intentions both internationally and nationally in order to detect
commonalities and differences to address the phenomenon. On this subject matter, many
studies have been performed on African American populations in comparison to their
White, non-Hispanic counterparts. These studies explored race, socioeconomic factors,
demographics, education level, trust in government agencies, and trust in health care
providers as possible determinants influencing the attitude and behavior of vaccine
uptake.
In “Exploring racial influences on flu vaccine attitudes and behavior: Results of a
national survey of White and African American adults,” researchers explore race, racism,
and racial influences as a public health concern that influences vaccine uptake because
“racism [contributes] to negative health outcomes” (Quinn et al 1168). The study
analyzes results from 1643 participants — 838 White participants and 819 Black
participants. Participants were surveyed through Growth from Knowledge (GfK), a data
and analysis company. In this survey, demographics and and flu vaccination behavior
intention questions were collected from participants, including sex, age, marital status,
education, income, and vaccine behavior and intentions. After completing demographic
questions, participants were asked questions that measured various concepts/variables.
The survey measures in question were “racial factors, trust & risk perception, vaccine
beliefs, flu vaccine knowledge, vaccine hesitancy and confidence, and social norms”
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(Quinn et al. Table 2 1170). Upon completion of the survey, participants were
compensated with a $5 cash equivalent. When the data were examined, 53.4% of White
non-Hispanic participants reported having gotten the flu shot in comparison to 44.4% of
African American, Non- Hispanic participants. The study also revealed statistically
significant vaccine attitudes among White Americans and African Americans, which
confirmed the hypothesis in question. It was reported White Americans had higher trust
in the flu vaccine, higher risk perception of flu, and lower vaccine risk perception
compared to African American participants. African Americans reported higher
perceived vaccine side effects risks than the actual disease. When examining the
variables measuring the influence of racial factors, it was reported that “racial
consciousness in a health care setting emerges as a more powerful influence for African
Americans, associated with lower trust in the vaccine and the vaccine process” (Quinn et
al 1167). African Americans had a higher level of skepticism about the vaccine and the
vaccine process than their White counterparts (Quinn et al 1173). This skepticism was
attributed to the medical mistrust within the healthcare field, with a specific emphasis on
the Tuskegee Syphilis Study in Tuskegee, Alabama. This study provides support for the
idea that African Americans' perceptions of vaccine safety perception, and thus vaccine
uptake, are correlated with racial influences among other factors.
In a similar study, “Socioeconomic status, demographics, beliefs, and A(H1N1)
vaccine uptake in the United States,” researchers explore the association between
socioeconomic factors and the H1N1 vaccine uptake. To do so, researchers surveyed
approximately 1600 Americans over the age of 18. Of the H1N1 related beliefs, two
examined were further examined: “those related to A(H1N1) perceived susceptibility and
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A(H1N1) vaccine safety” (Galatea, Minsky, Viswanath 5285). There were three
independent variables tested in this study socioeconomic status and demographics, H1N1
related beliefs, and seasonal flu vaccination uptake. The dependent variable was the
H1N1 vaccine uptake. After the survey was completed, researchers performed a series of
regression models. Their first model revealed a relationship between a few of the
demographic factors. The final regression model revealed a correlation between age and
vaccine uptake with younger participants being more likely to be vaccinated. In addition
to age, it was determined vaccine safety perception influenced the uptake of the H1N1
vaccine. Their results yielded an association between age, urbanicity, and H1N1 flu
vaccine safety and H1N1 vaccinations (Galatea, Minsky, Viswanath 5288). Though
limitations of this study included only studying the uptake for one particular flu vaccine,
the results drawn from vaccine hesitancy and its relation to vaccine uptake may be
applied to future vaccine issues, such as the COVID-19 Vaccine.
In “Black-white disparities in 2009 H1N1 vaccination among adults in the United
States: A cautionary tale for the COVID-19 pandemic,” researchers use the prior research
on the H1N1 vaccine uptake beliefs and intentions as precedent to what could occur in
relation to the COVID-19 vaccine. In this study, researchers used data from the National
2009 H1N1 Flu Survey to examine the H1N1 pandemic among black women, black men,
white women, and white men. The data from this study comes from the National 2009
H1N1 Flu Survey which was administered over 8 months beginning in October of 2009.
Like previous studies, this study also acknowledged the health disparities among minority
populations, and in this case, black participants. Unlike other studies, this study explored
sex and race as a paired entity in relation to H1N1 Vaccinations. Their goal was to
9

examine the role of “health beliefs, socioeconomic status (SES), pre-existing conditions,
and healthcare” to determine disparities in vaccination uptake. In a study examining race
and sex as a combined factor, the results revealed black females were least likely to
report against the flu vaccination while black females were the most likely to (Burger,
Reuther, Mamelund et al. 946). The study also showed black participants were more
likely to express concern or doubt about receiving the vaccine in comparison to their
white counterparts (Burger et al. 943). Because of their findings, they suggest health care
professionals use their findings as an indication of the COVID-19 vaccine uptakes.
In “Correlates of COVID-19 Vaccine Hesitancy among a Community Sample of
African Americans Living in the Southern United States,” researchers address the
disproportionality of COVID-19 Vaccinations among African Americans living in
Central Savannah River Area in Georgia (Moore 1). Researchers sampled 257
community members between December 2020 and April 2021. During this time,
researchers were seeking to find vaccine hesitancy determinants. Researchers solicited
participants over the age of 18 years old for this study during another study, the
SeroPrevalence And Respiratory Tract Assessment (SPARTA). In their survey, they
collected both demographics on each participant in addition to questions assessing
subjects’ beliefs on COVID-19. These five questions asked to determine their beliefs. Of
their 257 participants, 68.1% of responses indicated acceptance, 16.3% indicated
resistance, and 15.6% indicated hesitancy. Results revealed African Americans who
experienced who housing insecurity due to COVID-19 were the most resistant to the
vaccination (Moore 14). By studying COVID-19 Vaccine hesitancy in African
Americans in the south, this study mimics and supports the research being conducted.
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Knowing of the COVID-19 Vaccination issue among African Americans,
researchers of “A Theory-Based Analysis of COVID-19 Vaccine Hesitancy among
African American in the United States: A Recent Evidence,” seeks to develop the theorybased interventions to combat this issue. Between July and August, researchers used a
psychometric valid questionnaire survey through Qualtrics to assess vaccine hesitancy in
428 unvaccinated African Americans. This Multi-Theory survey model asked participants
15 demographical questions in addition to 13 COVID-19 vaccine behavior questions. In
total, four constructs were examined throughout this model: advantages of COVID-19
vaccination, disadvantages of COVID-19 vaccinations, behavioral confidence, and
changes in the physical environment (Table 1: Framework of MTM). Initial results
revealed nearly half of the participants were hesitant to receive the COVID-19 vaccine.
Of the vaccine-hesitant population, they were concerned with the long-term efficiency of
the vaccine. When final regressions and results were examined, “MTM constructs
predicted nearly 65% of variance” in COVID-19 vaccine uptake within the vaccinehesitant group. (Sharma, Batra, K., Batra, R. 1). Based on these findings, they proposed
an educational session on COVID-19 Vaccine should take place in hopes of increasing
the number of vaccinated African Americans.
The literature examined supports the presence of vaccine hesitancy among
African American populations. All results and findings of this literature not only
give health care professionals insight into COVID-19 vaccination uptake data may look
amongst African Americans, but also insight on how to potentially increase vaccination
among African Americans by addressing the causes listed in the literature.
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METHODS
The Mississippi INBRE Vaccine Hesitancy survey was utilized for this study. The
data was designed to examine COVID-19 vaccine hesitancy and related factors among
Mississippians following the SAGE Working Group on Vaccine Hesitancy model (Three
Cs Model of Vaccine Hesitancy). The data was collected from June 2021 to February
2022. Before participating in the survey, participants were notified of the purpose of the
survey which was to explore factors that influenced vaccine uptake among
Mississippians. Eligible participants were adults (>18 years of age) residents of
Mississippi. Participation solicitation was done through social media, e-mail and other
electronic means through social networks of the Mississippi INBRE Community
Engagement and Training Core, research staff/students, and community-based
organizations. Upon successful completion of the survey, participants were offered an
electronic twenty-dollar Walmart gift card as compensation for completion. While 564
participants completed the study, only African Americans were selected from the total
sample to examine the perception of COVID-19 vaccine safety and vaccine hesitancy
among African American Mississippi residents.
Variables Description
Independent Variables
For this study, there were two kinds of independent variables: independent
variables of interest and control or accounted independent variables. Vaccine safety
perceptions were measured based on two variables. The first was a 7-point Likert
agreement response from strongly disagree to strongly agree to the statement, “I am
concerned about the safety of the COVID-19 vaccine.” The second was a 7-point Likert
12

agreement response from strongly disagree to strongly agree to the statement, “The
COVID-19 vaccine is safe for me and my community.” Variables accounted for included
age, gender, education level, household income level, having past experiences that
discouraged you from receiving COVID-19 vaccine, and knowing a family member or
close friend to have an adverse reaction to the vaccine.
Dependent Variables
The dependent variable explored was vaccine hesitancy. This variable was created
based on the SAGE working group model by combining two variables: VAC_1 (Have
you received the 1st dose of a COVID-19 Vaccine?) and VAC_2b (How likely are you to
get the COVID-19 vaccine in the next 3 months?). Participants’ answers to these
questions were used to measure the likelihood of vaccine uptake. For question VAC_1,
participants’ survey choices were ‘yes’ and ‘no.’ For question VAC_2b, survey choices
were the 7-point Likert agreement response from extremely unlikely to extremely likely.
There was also an option for “received 1st dose of COVID-19 vaccine.”
Statistical Analysis
Descriptive, frequency, correlation, and linear regression analyses were conducted
using IBM SPSS Statistics 27.0 software. Mean +/- standard deviation was calculated and
provided for age, and frequencies were calculated to determine data distribution for
categorical variables. Pearson correlation analysis was computed to examine the
relationship between potential control variables and the dependent variable.
Linear regression was computed to determine the ability of the independent variables to
predict vaccine hesitancy, after controlling for select perceptions and demographics.
Alpha level </= 0.05 was considered statistically significant.
13

RESULTS
Survey participants for this study included 268 African American Mississippians
over the age of 18 years old. Though exploring the variables that old influence vaccine
uptake, demographic variables for each participant was recorded and accounted for.
These variables included age, gender, education level, and income level. Table 1 displays
full demographic information for the population sample.
Table 1: Demographic Variables
Mean

SD

n

%

37.61

14.078

268

100.0%

Men

103

38.4%

Women

164

61.2%

Unknown

1

0.4%

2

0.7%

A high school degree

29

10.8%

Some college, but not a college

58

21.6%

A 2-year or vocational degree

29

10.8%

A 4-year college degree or

150

56.0%

$0 to $19,999

40

14.9%

$20,000 to $29,999

35

13.1%

$30,000 to $39,999

31

11.6%

$40,000 to $49,999

26

9.7%

$50,000 to $59,999

19

7.1%

Age
Gender

Education Level Less than a high school degree

degree

higher
Income Level:

14

$60,000 to $69,999

23

8.6%

$70,000 to $79,999

19

7.1%

$80,000 to $99,999

26

9.7%

$100,000 to $119,999

13

4.9%

$120,000 to $139,999

12

4.5%

$140,000 or greater

24

9.0%

Correlation analyses revealed a significant linear relationship between vaccine
hesitancy and knowing a family member who had a bad reaction, age, education, and
household income level, but not gender or remembering past events. Table 2 contains
complete correlation analysis results. Thus, control variables for regression analyses were
determined to be knowing a family member who had a bad reaction, age, education, and
household income level.
Table 2: Correlations
Past

Knowing

Age

Discouraging

someone who

Events

had a Bad

Gender

Education

Household

Level

Income Level

Reaction
Vaccine

r

.110

.182**

-.395**

-.038

-.177**

-.195**

p-value

.073

.003

.000

.538

.004

.001

n

268

268

268

267

268

268

Hesitancy

15

Table 3 contains complete regression analyses and model summary information.
Model 1 included demographic predicators only and accounted for 16.1% of the total
variation in vaccine hesitancy. Model 2 included demographics and select perceptions,
which accounted for 19.0% of the total variation in vaccine hesitancy. Model 3 included
Model 2 control variables and the two main predictors, which accounted for 39.7% of the
total variation in vaccine hesitancy. Agreement with concern about the safety of the
COVID-19 vaccine was not a significant predictor of vaccine hesitancy.
Table 3: Regression Analyses and Model Summary Results
Unstandardized Coefficients Standardized
Coefficients
Model
1

B
Constant

Std. Error
-4.018

.540

Age

-.060

.010

Education

-.092

Income Level

Beta

t

Sig.
-7.441

.000

-.364

-5.734

.000

.129

-.044

-.707

.480

-.031

.046

-.044

-.688

.492

-4.274

.538

-7.943

.000

Age

-.061

.010

-.370

-5.924

.000

Education

-.104

.127

-.051

-.817

.415

Income Level

-.006

.046

-.008

-.130

.897

Bad Reaction

.968

.317

.175

3.055

.002

-1.222

.646

-1.890

.060

Age

-.038

.009

-.232

-4.140

.000

Education Level

-.094

.111

-.045

-.845

.399

R2=0.16, F=16.46, p<0.001
2

Constant

R2=0.19, F=15.07, p<0.001
3

Constant

16

Income Level

.008

.040

.011

.191

.848

Bad Reaction

.412

.285

.074

1.446

.150

-.018

.069

-.013

-.262

.794

-.728

.078

-.491

-9.361

.000

COVID-19
Vaccine Safety
Concerns
COVID-19
Vaccine is safe
for me and the
community.
R2=0.40, F=28.01, p<0.001

Results also showed each of the models was a significant predictor of vaccine
hesitancy. For Model 1, age was a significant predictor of vaccine hesitancy where for
each increase in age by 1.0-year, vaccine hesitancy decreased by 0.364, after controlling
for education and household income levels. For Model 2, knowing a family member or
close friend with a bad COVID-19 vaccine reaction was a significant predictor of vaccine
hesitancy, indicating that vaccine hesitancy is higher for those who knew someone than
for those who did not, after controlling for age, education, and household income. For
Model 3, the perception that COVID-19 vaccine was safe for self and community was a
significant predictor of vaccine hesitancy, indicating that 1.0 unit increase in agreement
with this perception, vaccine hesitancy decreased by 0.491 units, after controlling for age,
education, household income, and knowing a family member or friend with a bad
reaction. Agreement with concern about the safety of the COVID-19 vaccine was not a
significant predictor of vaccine hesitancy.
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In the survey, participants were asked if there were events that discouraged their
likelihood of receiving the COVID-19 Vaccine. If participants answered yes, they were
able to expand on the specific events that discouraged them. Of the 268 participants
surveyed, 66 participants indicated they remembered events that discouraged them from
receiving the vaccine. These responses were placed in four categories: Historical Events,
Side Effects & Adverse Health Events, Governmental & Organizational Mistrust, and
Other. Of the 66 participant responses, 57.6% of responses credited side effects and
adverse health events, 18.2% of responses credited other influences, 12.1% of responses
credited governmental and organizational mistrust, and another 12.1% of responses
credited historical events, including the Tuskegee Experiment.
Table 4: Events Discouraging COVID-19 Vaccine Uptake
Categories

n

%

Historical Events:

8

12.1%

Side Effects & Adverse Health

38

57.6%

8

12.1%

12

18.2%

Events:
Governmental & Organizational
Mistrust:
Other:
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DISCUSSION AND CONCLUSIONS
The Sage Working Group defined Vaccine Hesitancy as the “delay in acceptance
or refusal of vaccination despite availability of vaccination services” (MacDonald 1).
Though present, the cause of this phenomenon cannot be summed up due to one
incidence but rather an accumulation of external influences such as health inequities and
disparities and socioeconomic determinants. In this study, we sought to determine if there
was a relationship between COVID-19 vaccine hesitancy and COVID-19 vaccine safety
perceptions in African American Mississippians. We wondered how African American
Mississippians’ decision to receive the COVID-19 vaccine may be influenced due by the
perceived quick development of the vaccines and the lack of data and research
surrounding long term side effects. With this question in mind, 268 African American
Mississippians were given an online survey to assess whether their vaccine safety
perceptions of the vaccine influenced their vaccine uptake decision. Participants reported
demographic variables (age, gender, education level, and household income level). They
also indicated their agreement or disagreement with the questions and statements relating
to the COVID-19 vaccine: I am concerned about the safety of the COVID-19 vaccine and
The COVID-19 vaccine is safe for me and my community. Based on the initial correlation
analysis, age, education, household income level, and knowing a family member who had
a bad reaction was set as control variables for regression analyses. Results from the
Pearson correlation analysis revealed the relationship between vaccine safety perceptions
and vaccine uptake were not statistically significant and thus not an effective predictor of
vaccine hesitancy in this population, but the other some of the demographic variables
were. Of the variables examined, age, education, household income, and knowing a
19

family member who had a bad reaction were found to be predictors of vaccine hesitancy
among the African American population examined.
While these results do not support literature charging vaccine safety perceptions
as a reason for vaccine hesitancy, the results do support published literature arguing
vaccine hesitancy is present among patients and African Americans, specifically. The
results also support other studies whose vaccine hesitancy determinants are age and
household income levels (Soares et al). Although these studies will continue to provide
clarity on vaccine hesitancy among African Americans and other minority groups, further
research is needed to explore how historical events such as the Tuskegee experiment and
the story of Henrietta Lacks may have influenced health care trust in African American
populations. Using these results, healthcare providers will be able to better address this
population who may have a learned mistrust of the government and healthcare system.
In conclusion, vaccine hesitancy is an idea heavily influencing vaccine uptake
against disease-causing pathogens. While this study sought to explore how COVID-19
vaccine safety perceptions influenced COVID-19 vaccine uptake, results revealed the
relationship between these two variables was not statistically significant and thus not an
effective predictor of vaccine hesitancy in this population. Though vaccine safety
perceptions were not a significant predictor of vaccine hesitancy, these findings give
healthcare professionals insight on how to proceed in addressing vaccine hesitant
individuals. Based on these findings, it is proposed healthcare professionals take a
number of actions in hopes of increasing vaccine uptake against future viral pathogens.
These actions include increasing educational efforts on the biological mechanism of the
vaccine, explaining the importance of vaccine uptake against viral infections, increasing
20

access and transportation to vaccine distribution centers, acknowledging events that may
have led to governmental and health care mistrust, and addressing varied vaccine
reactions among individuals.
Limitations in the study design included generalizability. Because subjects in
question were only African American Mississippi residents, the reasonings causing
vaccine hesitancy in this population may or may not be applicable to all other races and
minority groups who are vaccine hesitant Because of that, further studies should also
examine vaccine hesitancy in a general population and mechanisms to increase vaccine
uptake among said population.
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SELECT SURVEY ITEMS USED FOR THIS STUDY
DEPENDENT VARIABLE: Vaccine Hesitancy
Vaccine Hesitancy: Combination of _Vac1 and Vac2b
a. Extremely unlikely to get vaccine in next 3 months (1)
b. Very Unlikely (2)
c. Somewhat Unlikely (3)
d. Neutral, neither likely or unlikely (4)
e. Somewhat likely (5)
f. Very Likely (6)
g. Extremely likely (7)
h. Received 1st dose of COVID-19 vaccine (8)
Vaccine Hesitancy was created based on the SAGE working group model
and by combining the two variables VAC_1 and VAC2b
VAC_1 Have you received the 1st dose of a COVID-19 vaccine? NOMINAL
a. Yes 1
b. No 0
VAC_2b How likely are you to get the COVID-19 vaccine in the next 3
months? NOMINAL
i. Extremely unlikely (1)
j. Very Unlikely (2)
k. Somewhat Unlikely (3)
l. Neutral, neither likely or unlikely (4)
m. Somewhat likely (5)
n. Very Likely (6)
o. Extremely likely (7)
INDEPENDENT VARIABLES OF INTEREST: Vaccine Safety Perceptions
IGVU_C_2 I am concerned about the safety of the COVID-19 vaccine ORDINAL
a. Strongly disagree (1)
b. Disagree (2)
c. Somewhat disagree (3)
d. Neither agree nor disagree (4)
e. Somewhat agree (5)
f. Agree (6)
g. Strongly agree (7)
VIVU_A_1The COVID-19 vaccine is safe for me and my community. ORDINAL
a. Strongly disagree (1)
b. Disagree (2)
c. Somewhat disagree (3)
d. Neither agree nor disagree (4)
e. Somewhat agree (5)
f. Agree (6)
g. Strongly agree (7)
CONTROL INDEPENDENT VARIABLES:
CIVU_C_1 Do you remember any events in the past that may have discouraged you
from getting a COVID-19 vaccine for yourself, even if you overcame it and got the
vaccine? NOMINAL
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a.
b.

Yes (1)
No (0) = skip the follow up question

CIVU_C_2 What event(s) do you remember that discouraged you from getting the
COVID-19 vaccine? NOMINAL
Text entry
IGVU_A_4 Do you know a family member or close friend who has had a bad reaction to
the COVID-19 vaccine? NOMINAL
a. Yes (1)
b. No (0)
Q2 AGE What is your age? Scale or Ratio
a. Enter years < Ineligible if <18
Q3 GENDER What is your gender? Nominal
a. Male (0)
b. Female (1)
Q7 EDUCATION Please indicate the highest level of education you have
received. Nominal
a. Less than a high school degree (1)
b. A high school degree (2)
c. Some college, but not a college degree (3)
d. A 2 year or vocational degree (4)
e. A 4-year college degree or higher (5)
Q10 What is your household current yearly net income level? In other words, think about
each person that pays the bills and contributes to household expenses. If you add up
what each of those people make, about how much money is brought home each year?
Ordinal
f. $0 to $19,999 (1)
g. $20,000 to $29,999 (2)
h. $30,000 to $39,999 (3)
i. $40,000 to $49,999 (4)
j. $50,000 to $59,999 (5)
k. $60,000 to $69,999 (6)
l. $70,000 to $79,999 (7)
m. $80,000 to $99,999 (8)
n. $100,000 to $119,999 (9)
o. $120,000 to $139,999 (10)
p. $140,000 or greater (11)
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